Author:
Campos Carolina,Colomer-Castell Sergi,Garcia-Cehic Damir,Gregori Josep,Andrés Cristina,Piñana Maria,González-Sánchez Alejandra,Borràs Blanca,Parés-Badell Oleguer,Adombi Caroline Melanie,Ibañez-Lligoña Marta,Esperalba Juliana,Codina Maria Gema,Rando-Segura Ariadna,Saubí Narcis,Esteban Juan Ignacio,Rodriguez-Frías Francisco,Pumarola Tomàs,Antón Andrés,Quer Josep
Abstract
AbstractThe SARS-CoV-2 Omicron variant emerged showing higher transmissibility and possibly higher resistance to current COVID-19 vaccines than other variants dominating the global pandemic. In March 2020 we performed a study in clinical samples, where we found that a portion of genomes in the SARS-CoV-2 viral population accumulated deletions immediately before the S1/S2 cleavage site (furin-like cleavage site, PRRAR/S) of the spike gene, generating a frameshift and appearance of a premature stop codon. The main aim of this study was to determine the frequency of defective deletions in prevalent variants from the first to sixth pandemic waves in our setting and discuss whether the differences observed might support epidemiological proposals. The complete SARS-CoV-2 spike gene was deeply studied by next-generation sequencing using the MiSeq platform. More than 90 million reads were obtained from respiratory swab specimens of 78 COVID-19 patients with mild infection caused by the predominant variants circulating in the Barcelona city area during the six pandemic waves: B.1.5, B.1.1, B.1.177, Alpha, Beta, Delta, and Omicron. The frequency of defective genomes found in variants dominating the first and second waves was similar to that seen in Omicron, but differed from the frequencies seen in the Alpha, Beta and Delta variants. The changing pattern of mutations seen in the various SARS-CoV-2 variants driving the pandemic waves over time can affect viral transmission and immune escape. Here we discuss the putative biological effects of defective deletions naturally occurring before the S1/S2 cleavage site during adaption of the virus to human infection.
Funder
Spanish Network for the Research in Infectious Diseases from the European Regional Development Fund
Pla Estratègic de Recerca i Innovació en Salut (PERIS) – Direcció General de Recerca i Innovació en Salut
Gilead’s biomedical research project
Centro para el Desarrollo Tecnológico Industrial (CDTI) from the Spanish Ministry of Economy and Business
Instituto de Salud Carlos III cofinanced by the European Regional Development Fund
Publisher
Springer Science and Business Media LLC
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献